Forum fights are a standard part of high-stakes litigation, with lawyers sometimes spending months or years arguing over ...
Bayer shares drop as Roundup settlement faces federal court shift, raising litigation risk and timeline doubts.
By Renee Hickman and Tom Polansek CHICAGO, June 2 (Reuters) - Bayer has no plans to spin off Monsanto, a representative said on Tuesday, even as the company faces an avalanche of lawsuits over its ...
Bayer AG BAYRY has ruled out a Monsanto spin-off for now despite facing mounting lawsuits tied to its Roundup weedkiller, a ...
Bayer shares fell after plaintiffs sought to transfer a proposed $7.25 billion U.S. settlement over Roundup weedkiller to a ...
Cancer victims argue the proposed $7.25 billion Roundup "sweetheart deal" benefits Bayer and lawyers more than those harmed by the herbicide.
A decision on the request could affect the timeline for one of the most closely watched developments in ongoing Roundup ...
Bayer has no plans to spin off Monsanto, a company representative told Reuters, even as the company faces a flurry of ...
Attorney Ashley Keller removed the case behind the $7.25 billion Roundup class action settlement to Missouri federal court on ...
Bayer has announced a proposed $7.25 billion settlement between its indirect subsidiary Monsanto and plaintiffs alleging that exposure to Roundup caused their non-Hodgkin lymphoma. Company leaders say ...
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Bayer's Monsanto unit has proposed a US$7.25b nationwide class-action settlement over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results